메뉴 건너뛰기




Volumn 23, Issue 1, 2000, Pages 77-82

The natural course of Gaucher disease in The Netherlands: Implications for monitoring of disease manifestations

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; ENZYME THERAPY; FEMALE; FOLLOW UP; GAUCHER DISEASE; HUMAN; MALE; MUTATION; NETHERLANDS; PATIENT MONITORING; RACE DIFFERENCE; RETROSPECTIVE STUDY;

EID: 0033967982     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005655031239     Document Type: Article
Times cited : (36)

References (9)
  • 1
    • 0025236339 scopus 로고
    • Therapeutic response to intravenous administration of glucocerebrosidase in a patient with Gaucher disease
    • Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO (1990) Therapeutic response to intravenous administration of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA 87: 1913-1916.
    • (1990) Proc Natl Acad Sci USA , vol.87 , pp. 1913-1916
    • Barton, N.W.1    Furbish, F.S.2    Murray, G.J.3    Garfield, M.4    Brady, R.O.5
  • 3
    • 0028875475 scopus 로고
    • The clinical course of treated and untreated Gaucher disease. A study of 45 patients
    • Beutler E, Demina A, Laubscher K, et al (1995) The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells, Mol Dis 21: 86-106.
    • (1995) Blood Cells, Mol Dis , vol.21 , pp. 86-106
    • Beutler, E.1    Demina, A.2    Laubscher, K.3
  • 4
    • 16944365284 scopus 로고    scopus 로고
    • Glucocerebrosidase genotype of Gaucher patients in the Netherlands: Limitations in prognostic value
    • Boot RG, Hollak CE, Verhoek M, et al (1997) Glucocerebrosidase genotype of Gaucher patients in the Netherlands: limitations in prognostic value. Hum Mutat 10: 348-358.
    • (1997) Hum Mutat , vol.10 , pp. 348-358
    • Boot, R.G.1    Hollak, C.E.2    Verhoek, M.3
  • 5
    • 0029066515 scopus 로고
    • Individualised low-dose alglucerase therapy for type 1 Gaucher's disease
    • Hollak CEM, Aerts JMFG, Goudsmit R, et al (1995) Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet 345: 1474-1478.
    • (1995) Lancet , vol.345 , pp. 1474-1478
    • Cem, H.1    Aerts, J.M.2    Goudsmit, R.3
  • 6
    • 0031899307 scopus 로고    scopus 로고
    • Type 1 Gaucher disease: Phenotypic expression and natural history in Japanese patients
    • Ida H, Rennert OM, Ito T, Maekawa K, Yoshikatsu E (1998) Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients. Blood cells, Mol Dis 24: 73-81.
    • (1998) Blood Cells, Mol Dis , vol.24 , pp. 73-81
    • Ida, H.1    Rennert, O.M.2    Ito, T.3    Maekawa, K.4    Yoshikatsu, E.5
  • 7
    • 0002584878 scopus 로고    scopus 로고
    • Facts and fiction of modern diagnosis of type 1 Gaucher disease: The German experience
    • Niederau C, Brikhahn A, Ehlen C, Haussinger D (1996) Facts and fiction of modern diagnosis of type 1 Gaucher disease: the German experience. Gaucher Clin Perspect 4: 5-13.
    • (1996) Gaucher Clin Perspect , vol.4 , pp. 5-13
    • Niederau, C.1    Brikhahn, A.2    Ehlen, C.3    Haussinger, D.4
  • 8
    • 0026348250 scopus 로고
    • Orthopedic problems in Dutch Gaucher patients
    • Poll RG, van den Hark ACBM (1991) Orthopedic problems in Dutch Gaucher patients. Acta Orthop Scand 62 (supplement 246): 31.
    • (1991) Acta Orthop Scand , vol.62 , Issue.246 SUPPL. , pp. 31
    • Poll, R.G.1    Van Den Hark, A.C.B.M.2
  • 9
    • 0026465017 scopus 로고
    • Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients
    • Zimran A, Kay A, Gelbart T, et al (1992) Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine 71: 337-353.
    • (1992) Medicine , vol.71 , pp. 337-353
    • Zimran, A.1    Kay, A.2    Gelbart, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.